Company intelligence / Profile preview
Onegene Biotechnology
South Korea [2]pmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Onegene Biotechnology is developing multi-modality biologic drugs using its proprietary UniStac® platform. The company’s lead programs include a tetra-specific treatment for NASH targeting both metabolic syndrome and the NLRP3 inflammasome, as well as tri-specific immunotherapies designed to modulate the tumor microenvironment. The company has presented at major international conferences but has not yet reported late-stage clinical results.[1][2]
- Therapeutic areas
- GastroenterologyOncology
- Modalities
- Multi-specific biologics (including tri-specific and tetra-specific drugs)Protein-protein conjugatesEnzyme-mediated protein engineering[1]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Participation in global conferences such as EASL, BIO Boston, Bio Japan; no specific pharma partnerships publicly disclosed.[1]
Beyond the preview
Go deeper on Onegene Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Onegene Biotechnology.